Geneos Wealth Management’s Helix Energy Solutions HLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,030
Closed -$24K 2669
2022
Q1
$24K Buy
+5,030
New +$20.6K ﹤0.01% 1714
2021
Q3
Sell
-412
Closed -$2K 2861
2021
Q2
$2K Hold
412
﹤0.01% 2659
2021
Q1
$1K Hold
412
﹤0.01% 3021
2020
Q4
$2K Buy
+412
New +$1.38K ﹤0.01% 2696
2020
Q3
Sell
-412
Closed -$1K 2660
2020
Q2
$1K Buy
+412
New +$1.11K ﹤0.01% 2468
2020
Q1
Sell
-412
Closed -$3K 2536
2019
Q4
$3K Sell
412
-818
-67% -$7.08K ﹤0.01% 2299
2019
Q3
$10K Buy
1,230
+1,000
+435% +$8.07K ﹤0.01% 1890
2019
Q2
$1K Hold
230
﹤0.01% 2408
2019
Q1
$1K Hold
230
﹤0.01% 2323
2018
Q4
$1K Hold
230
﹤0.01% 2305
2018
Q3
$2K Hold
230
﹤0.01% 2254
2018
Q2
$1K Hold
230
﹤0.01% 2189
2018
Q1
$1K Hold
230
﹤0.01% 2100
2017
Q4
$1K Hold
230
﹤0.01% 2099
2017
Q3
$1K Hold
230
﹤0.01% 2044
2017
Q2
$1K Hold
230
﹤0.01% 1996
2017
Q1
$1K Hold
230
﹤0.01% 1986
2016
Q4
$2K Hold
230
﹤0.01% 1862
2016
Q3
$1K Hold
230
﹤0.01% 1883
2016
Q2
$1K Hold
230
﹤0.01% 1742
2016
Q1
$1K Buy
+230
New +$970 ﹤0.01% 1724

Other funds holding HLX

Geneos Wealth Management's HLX Position: Q2 2022 in Review

Geneos Wealth Management sold out of Helix Energy Solutions (HLX) in Q2 2022, closing a stake of 5,030 shares — an estimated $24K sold.

Geneos Wealth Management first reported a position in HLX in Q1 2016 and held it in 21 quarters. The position peaked at $24K in Q1 2022. 190 funds tracked by Wall St. Rank hold HLX as of Q2 2022.

  • Geneos Wealth Management reported no remaining Helix Energy Solutions position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 5,030 Helix Energy Solutions shares in Q2 2022, an estimated $24K.
  • Geneos Wealth Management first reported a position in Helix Energy Solutions in Q1 2016 and held it in 21 quarters.
  • Geneos Wealth Management's Helix Energy Solutions position peaked at $24K in Q1 2022.
  • 190 funds tracked by Wall St. Rank held Helix Energy Solutions as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.